Myocardial Fibrosis Assessment at 3-T versus 5-T Myocardial Late Gadolinium Enhancement MRI: Early Results

被引:1
|
作者
Guo, Yubo [1 ]
Lin, Lu [1 ]
Zhao, Shihai [1 ]
Sun, Gan [2 ]
Chen, Yuyan [3 ]
Xue, Ke [3 ]
Yang, Yuxin [3 ]
Chen, Shuo [3 ]
Zhang, Yan [3 ]
Li, Guobin [4 ]
Zhu, Yanjie [5 ]
Vliegenthart, Rozemarijn [6 ]
Wang, Yining [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Dermatol, State Key Lab Complex Severe & Rare Dis, 1 Shuaifuyuan, Beijing 100730, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Inst Clin Med, Theranost & Translat Res Ctr,Natl Infrastruct Tran, Beijing, Peoples R China
[3] United Imaging Res Inst Intelligent Imaging, Beijing, Peoples R China
[4] Shanghai United Imaging Healthcare, Shanghai, Peoples R China
[5] Chinese Acad Sci, Shenzhen Inst Adv Technol, Paul C Lauterbur Res Ctr Biomed Imaging, Shenzhen, Peoples R China
[6] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands
基金
中国国家自然科学基金;
关键词
CONTRAST ENHANCEMENT; BRAIN-TUMORS; INFARCTION; 3-TESLA; HALF;
D O I
10.1148/radiol.233424
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: Cardiac MRI at 5 T has recently become available and potentially improves tissue contrast enhancement at gadolinium chelate-enhanced T1-weighted imaging. Purpose: To evaluate the feasibility of 5-T myocardial late gadolinium enhancement (LGE) MRI in assessing myocardial fibrosis by comparing image quality and LGE quantification with reference-standard 3-T myocardial LGE MRI. Materials and Methods: Consecutive patients with confirmed myocardial fibrosis on previous 3-T MRI scans between January 2023 and July 2023 prospectively underwent follow-up imaging from August 2023 to November 2023. Each participant underwent follow-up 5-T imaging using an identical dose of contrast agent. Radiologist scoring of image quality using a Likert scale (range, 1-5), signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), contrast ratio, and semiautomatic quantitative LGE assessment were obtained and reported as medians and IQRs. Paired Wilcoxon signed rank tests were used to compare characteristics derived at 3-T and 5-T imaging. Results: A total of 18 participants (mean age, 49 years +/- 17 [SD]; nine male participants) were included, with a mean interval of 6.2 months +/- 2.3 between undergoing 3-T and 5-T MRI. Median image quality scores were 4.0 (IQR, 3.0-4.2) at 3 T and 4.0 (IQR, 3.0-4.4) at 5 T (P = .45). SNR at 5 T was higher than at 3 T (183.7 [IQR, 147.2-255.9] vs 125.8 [IQR, 108.2-171.6], respectively; P = .002). Median CNR at 5 T was higher than at 3 T in normal myocardium (50.8 [IQR, 35.4-67.9] vs 16.5 [IQR, 11.3-24.6], respectively) and pericardial fat (21.4 [IQR, 7.1-29.3] vs -5.0 [IQR, -16.4 to -2.3], respectively) (both P < .001). There was no evidence of a difference in the percentage of LGE quantified between 5 T and 3 T (median, 11.8% [IQR, 7.7%-20.5%] vs 12.6% [IQR, 6.6%-20.4%], respectively; P = .81). Conclusion: Myocardial LGE MRI at 5 T was found to be feasible, with no evidence of differences in subjective image quality and myocardial fibrosis quantification compared with 3-T myocardial LGE MRI. Furthermore, with use of identical contrast agent doses, SNRs and CNRs were improved at 5 T.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Peri-infarct dysfunction in post-myocardial infarction: assessment of 3-T tagged and late enhancement MRI
    Yuma Inoue
    Xiaomei Yang
    Michinobu Nagao
    Hiroshi Higashino
    Kohei Hosokawa
    Teruhito Kido
    Akira Kurata
    Hideki Okayama
    Jitsuo Higaki
    Teruhito Mochizuki
    Kenya Murase
    European Radiology, 2010, 20 : 1139 - 1148
  • [2] Peri-infarct dysfunction in post-myocardial infarction: assessment of 3-T tagged and late enhancement MRI
    Inoue, Yuma
    Yang, Xiaomei
    Nagao, Michinobu
    Higashino, Hiroshi
    Hosokawa, Kohei
    Kido, Teruhito
    Kurata, Akira
    Okayama, Hideki
    Higaki, Jitsuo
    Mochizuki, Teruhito
    Murase, Kenya
    EUROPEAN RADIOLOGY, 2010, 20 (05) : 1139 - 1148
  • [3] Assessment of the left atrial myocardial fibrosis of atrial fibrillation with late Gadolinium enhancement MRI
    窦丽娜
    ChinaMedicalAbstracts(InternalMedicine), 2018, 35 (02) : 66 - 66
  • [4] Cardiac MRI T1 Mapping Noninvasively Predicts Interstitial Myocardial Fibrosis in the Absence of Late Gadolinium Enhancement
    Sibley, Christopher T.
    Noureldin, Radwa A.
    Gai, Neville
    Nacif, Marcelo Souto
    Mudd, James O.
    Halushka, Marc K.
    Bluemke, David A.
    CIRCULATION, 2010, 122 (21)
  • [5] Could native T1 mapping replace late gadolinium enhancement in the assessment of myocardial fibrosis in patients with cardiomyopathy?
    Elsafty, Hend G.
    El Shafey, Mohammed
    El Arabawy, Reda
    Mahrous, Mary Rabea
    Dawoud, Tamer Mahmoud
    EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2021, 52 (01):
  • [6] Could native T1 mapping replace late gadolinium enhancement in the assessment of myocardial fibrosis in patients with cardiomyopathy?
    Hend G Elsafty
    Mohammed El Shafey
    Reda El Arabawy
    Mary Rabea Mahrous
    Tamer Mahmoud Dawoud
    Egyptian Journal of Radiology and Nuclear Medicine, 52
  • [7] Emerging Concepts for Myocardial Late Gadolinium Enhancement MRI
    Doltra, Adelina
    Amundsen, Brage Hoyem
    Gebker, Rolf
    Fleck, Eckart
    Kelle, Sebastian
    CURRENT CARDIOLOGY REVIEWS, 2013, 9 (03) : 185 - 190
  • [8] Assessment of myocardial fibrosis with T1 mapping MRI
    Everett, R. J.
    Stirrat, C. G.
    Semple, S. I. R.
    Newby, D. E.
    Dweck, M. R.
    Mirsadraee, S.
    CLINICAL RADIOLOGY, 2016, 71 (08) : 768 - 778
  • [9] Role of Late Gadolinium Enhancement in the Assessment of Myocardial Viability
    Shah, Viraj
    Kalekar, Tushar
    Gupta, Arunima
    Lamghare, Purnachandra
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (03)
  • [10] Quantification of myocardial viability in late Gadolinium enhancement Cardiac MRI
    Carminati, M. Chiara
    Boniotti, Cinzia
    Pepi, Mauro
    Caiani, Enrico G.
    2015 COMPUTING IN CARDIOLOGY CONFERENCE (CINC), 2015, 42 : 97 - 100